1. |
Lu T, Seto WK, Zhu RX, et al. Prevention of hepatocellular carcinoma in chronic viral hepatitis B and C infection. World J Gastroenterol 2013; 19:8887-94.
|
2. |
Lu J, Zhou Y, Lin X, et al. General epidemiological parameters of viral hepatitis A, B, C, and E in six regions of China: a cross-sectional study in 2007.PLoS One 2009; 4:e8467.
|
3. |
Yuen MF, Hou JL, Chutaputti A, et al. Hepatocellular carci- noma in the Asia pacific region. J Gastroenterol Hepatol 2009; 24:346-53.
|
4. |
Liaw YF, Chu CM. Hepatitis B virus infection. Lancet 2009; 373:582-92.
|
5. |
Chang MH, You SL, Chen CJ, et al. Decreased incidence of hepatocellular carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J Natl Cancer Inst 2009; 101:1348-55.
|
6. |
Aspinall EJ, Hawkins G, Fraser A, et al. Hepatitis B pre- vention, diagnosis, treatment and care: a review. Occup Med (Lond) 2011; 61:531-40.
|
7. |
Lavanchy D. Viral hepatitis: global goals for vaccination. J Clin Virol 2012; 55:296-302.
|
8. |
Baig S. Gender disparity in infections of Hepatitis B virus. J Coll Physicians Surg Pak 2009; 19:598-600.
|
9. |
Honda A, Yokosuka O, Suzuki K, et al. Detection of mutations in hepatitis B virus enhancer 2/core promoter and X protein regions in patients with fatal hepatitis B virus infection. J Med Virol 2000; 62:167-76.
|
10 |
Chan HL, Thompson A, Martinot-Peignoux M, et al. Hepatitis B surface antigen quantification: why and how to use it in 2011-A core group report. J Hepatol 2011; 55:1121-31.
|
11 |
Nguyen T, Thompson AJ, Bowden S, et al. Hepatitis B surface antigen levels during the natural history of chronic hepatitis B: a perspective on Asia. J Hepatol 2010; 52: 508-13.
|
12 |
Thompson AJ, Nguyen T, Iser D, et al. Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase in?uences correlation with viral load and intrahepatic hepatitis B virus markers. Hepatology 2010; 51:1933- 44.
|
13 |
Jaroszewicz J, Calle Serrano B, Wursthorn K, et al. Hepatitis B surface antigen (HBsAg) levels in the natural history of hepatitis B virus (HBV)-infection: a European perspective. J Hepatol 2010; 52:514-22.
|
14 |
Martinot-Peignoux M, Lapalus M, Asselah T, et al. The role of HBsAg quantification for monitoring natural history and treatment outcome. Liver Int 2013; 33 Suppl 1:125-32.
|
15 |
Tseng TC, Liu CJ, Yang WT, et al. Hepatitis B surface antigen level complements viral load in predicting viral reactivation in spontaneous HBeAg seroconverters. J Gastroenterol Hepatol 2014; 29:1242-9.
|
16 |
Miri SM, Alavian SM. Risk factors of hepatitis B infection: health policy makers should be aware of their importance in each community. Hepat Mon 2011; 11:238-9.
|